In addition, increased methylation at a CpG site (cg11669516) and reduced gene expression of insulin-like growth factor binding protein 2 (IGFPB2) are often found in mice and patients with NAFLD and NASH (Ahrens et al., 2013). The gene discussed is IGFBP2; the disease is metabolic dysfunction-associated steatohepatitis.